ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that the following presentation by Company management at an upcoming investor conference will be webcast:
•34th Annual Canaccord Genuity Growth Conference 3:30pm ET, August 13, Boston, MA
Help employers find you! Check out all the jobs and post your resume.
